Novartis sets price of MS drug

Novartis AG (NYSE:NVS; SIX:NOVN) said the wholesale acquisition cost of oral multiple sclerosis (MS) drug Gilenya fingolimod will be about $3,700 per 28-day supply, with an annual cost of about $48,00...